Johnson & Johnson Press Releases

JNJ 
$104.59
*  
0.31
0.3%
Get JNJ Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
12/24/2014 4:55:00 AM - PR Newswire
▲0.30 % Price Change since this news event. The Volume Ratio is 0.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biosense Webster, Inc. Launches Outcomes-Based, Risk-Sharing Program to Reinforce Significant Patient Benefits Demonstrated by Company’s Leading Contact Force Therapy
12/19/2014 9:43:00 AM - Business Wire
▼-1.72 % Price Change since this news event. The Volume Ratio is 1.67.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson to Host Fourth-Quarter/Full-Year 2014 Investor Conference Call on Results
12/17/2014 10:00:00 AM - PR Newswire
▲1.25 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson Announces Collaboration between Janssen and USAID to Expand Access to Anti-Multidrug-Resistant Tuberculosis (MDR-TB) Compound
12/11/2014 4:30:00 PM - PR Newswire


APAC Joint Replacement Market to Reach $6.4 Billion by 2020
12/10/2014 8:46:00 AM - PR Newswire
▼-3.02 % Price Change since this news event. The Volume Ratio is 1.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CloSys Appoints New Leadership and Board Members to Guide Corporate Revitalization, Complete Pivotal U.S. Clinical Trial
12/8/2014 5:41:00 PM - eTeligis


GTCR Completes Sale of Devicor Medical Products
12/4/2014 9:28:00 AM - Business Wire


Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013
12/1/2014 10:09:00 AM - PR Newswire
▼-3.54 % Price Change since this news event. The Volume Ratio is 0.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson Partners with Save the Children to Help Millions of Children over the Next Three Years
11/19/2014 8:20:00 PM - PR Newswire


Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate
11/19/2014 9:00:00 AM - PR Newswire


Nodality Develops Disease-Associated PD-1 Assay System for Application in Immuno-oncology
11/19/2014 8:00:00 AM - Business Wire


Nodality, Inc. Announces Data Presentation from Collaborative Program with UCB at American College of Rheumatology 2014 Annual Meeting
11/18/2014 8:00:00 AM - Business Wire


Nodality, Inc. Announces Data Presentations from Systemic Lupus Erythematosus Collaborative Programs at American College of Rheumatology 2014 Annual Meeting
11/17/2014 8:30:00 AM - Business Wire


CORRECTING and REPLACING Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM
11/10/2014 8:00:00 AM - Business Wire


Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM
11/10/2014 8:00:00 AM - Business Wire
▼-3.60 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson Announces Completion Of Alios BioPharma Acquisition
11/7/2014 4:05:00 PM - PR Newswire
▼-3.34 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Alios BioPharma to Present Preclinical Data on Its Anti-HCV Nucleotides AL-335 and AL-516 at the 2014 American Association for the Study of Liver Diseases Annual Meeting
11/6/2014 4:15:00 PM - Market Wire
▼-4.05 % Price Change since this news event. The Volume Ratio is 0.93.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances
10/28/2014 4:00:00 PM - PR Newswire
▼-0.11 % Price Change since this news event. The Volume Ratio is 1.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


GTCR Announces Sale of Devicor Medical Products
10/28/2014 7:31:00 AM - Business Wire


Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production
10/22/2014 2:02:00 AM - PR Newswire
▲4.17 % Price Change since this news event. The Volume Ratio is 0.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2014
10/16/2014 7:45:00 AM - PR Newswire
▲7.89 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Johnson & Johnson Family of Consumer Companies Turns Brands Purple in Support of Spirit Day
10/15/2014 9:00:00 AM - PR Newswire


Johnson & Johnson Reports 2014 Third-Quarter Results:
10/14/2014 7:45:00 AM - PR Newswire
▲4.90 % Price Change since this news event. The Volume Ratio is 2.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Alios BioPharma Presented Positive Results of Its Anti-RSV Nucleoside Analog AL-8176 in a Phase 2 Challenge Study in Adults Infected With Respiratory Syncytial Virus (RSV) at IDWeek
10/13/2014 8:30:00 AM - Market Wire
▲3.35 % Price Change since this news event. The Volume Ratio is 1.4.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma
10/13/2014 8:00:00 AM - Business Wire